L-ribofuranosyl nucleosides

Details L-ribofuranosyl nucleosides L-ribofuranosyl nucleosides

1994-10-24

1996-09-24

Wilson, James O.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 46, 514 49, 514 50, 536 2714, 536 2721, 536 276, 536 2762, 536 278, 536 2781, 536 282, 536 285, 536 2853, 536 2854, 536 2855, A61K 3170, C07H 1900

Patent

active

055591019

ABSTRACT:
This invention relates to .alpha. and .beta. L-ribofuranosyl nucleosides, processes for their preparation, pharmaceutical compositions containing them, and methods of using them to treat various diseases in mammals.

REFERENCES:
patent: 3457255 (1969-07-01), Jones et al.
patent: 3817982 (1974-06-01), Verheyden et al.
patent: 4340729 (1982-07-01), D'Souza et al.
patent: 4659698 (1987-04-01), Imbach et al.
patent: 4880782 (1989-11-01), Eckstein et al.
patent: 4918056 (1990-04-01), Bobek et al.
H. Aoyama, Bull. Chem. Soc. Jpn., 60:2073-2077 (1987).
M. Asai, et al., Chem. Pharm. Bull., 15(12), 1863-1870 (1967).
U. Asseline, et al., Nucleic Acids Research, vol. 19, No. 15, 4067-4074 (1991).
M. V. Baud, et al., Tetrahedon Letters, vol. 31, No. 31, 4437-4440 (1990).
A. Bloch, et al., J. Chem. vol. 10, No. 5, 908-912 (1967).
G. Etzold, et al., Chem. Ber., 101:226-234 (1968).
V. Fucik, et al., Nucleic Acids Research, vol. 1, No. 4, 639-644, Apr. 1974.
S. Fujimori, et al., Nucleosides & Nucleotides, 11(2-4), 341-349 (1992).
C. Genu-Dellac, et al., Nucleosides & Nucleotides, 10(6), 1345-1376 (1991).
C. Genu-Dellac, et al., Antiviral Chem. & Chemother. 2(2), 83-92 (1991).
C. Genu-Dellac, et al., Tet. Letters, vol. 32, No. 1, 79-82 (1991).
G. Gosselin, et al., Antimicrob. Agents Chemother., vol. 38, No. 6, 1292-1297, Jun. 1994.
J. G. Gu, et al., J. Neurochemistry, vol. 56, 548-552 (1991).
A. Holy, Nucleic Acid Chemistry, Part 1, 347-353, Eds. L. B. Townsend and R. S. Tipson, Wiley & Sons, New York (1978).
A. Holy, et al., Biol. Chem. Hoppe-Seyler, 366:355-359, Apr. 1985.
A. Holy, Nucleic Acid Chemistry, vol. 2, 527-532 (1978).
A. Holy, et al., coll. Czech. Chem. Commun., vol. 34, 3383-3401 (1969).
M. Jurovcik, et al., Febs Letters, vol. 18, No. 2, 274-276 (1971).
A. M. Kritzyn, et al., Coll. Czech. Chem. Commun., vol. 40, 3211-3219 (1975).
P. Langen et al., Progress in Antimicrobial and Anticancer Chemotherapy, Proceedings of the 6th International Congress of Chemotherapy, University Park Press, England, 1970, vol. II, 394-397.
K. F. Lau, et al., Cancer Chemotherapy Reports, Part II, vol. 3, 95-109 (1972).
L. M. Lerner, Preparation of Nucleosides, vol. 34, No. 1, 101-103 (1969).
T-S Lin, et al., Biochem. Pharma., vol. 47, No. 2, 171-174 (1994).
M. Miwa, et al., Chem. Pharm. Bull., 38(4), 998-1003 (1990).
D. H. Murray, et al., J. Phar. Sci., vol. 56, No. 7, 865-870 (1967).
N. Nagasawa, et al., J. Org. Chem., 32:251-252 (1967).
C. Perigaud, et al., Nucleosides & Nucleotides, 11(2-4), 903-945 (1992).
S. Savithiry, et al., Physiol. Plant., 84:460-466 (1992).
B. Schwarz, et al., Coll. Czech. Chem. Commun. 45:3217-3230 (1980).
B. Shimizu, et al., Chem. Pharm. Bull., 15(12):2011-2014 (1967).
B. Shimizu, et al., Nucleic Acid Chemistry, vol. 2, 783-792 (1978).
S. Spadari, J. Med. Chem., 35:4214-4220 (1992).
R. A. Taube, et al., Biochimica et Biophysica Acta, 255:6-18 (1972).
I. Votruba, et al., Febs Letters, vol. 19, No. 2, 136-138 (1971).
M. A. Waqar, et al., J. Cell. Physiol., 121:402-408 (1984).
A. F. Wu, et al., Biochemistry, 63:1222-1226 (1969).

Affiliated with

Also associated with

Rating

L-ribofuranosyl nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with L-ribofuranosyl nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and L-ribofuranosyl nucleosides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1928497